Transradial versus transfemoral intervention in ST-segment elevation myocardial infarction patients in Korean population
0
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background/Aims: Transradial intervention (TRI) is becoming the preferred method over transfemoral intervention (TFI) because TRI is associated with lower incidence of major bleeding and vascular complications. However, there has been limited published data regarding the clinical outcomes of TRI versus TFI in Korean patients with ST-elevation myocardial infarction (STEMI). Methods: A total of 689 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) from January to December of 2009 at nine university hospitals were enrolled in this study. Mid-term angiographic and 12-month cumulative clinical outcomes of the TRI group (n = 220, 31.9%) were compared to those of the TFI group (n = 469, 28.1%). Results: After propensity score matching, in-hospital complications and the 12-month major clinical outcomes during follow-up in the two groups were similar to each other. However, the incidence rates of repeat revascularization (6.4% vs. 0.5%, p = 0.003), target vessel revascularization (6.4% vs. 0.5%, p = 0.003), and major adverse cardiac events (MACE; 11.6% vs. 4.6%, p = 0.018) in the TFI group were higher than those in the TRI group during the 12-month of follow-up. Conclusions: In our study, TRI in STEMI patients undergoing primary PCI with DESs was associated with lower incidence of access site hematoma, 12-month repeat revascularization, and MACE compared to TFI. Therefore, TRI might play an important role in reducing bleeding complications while improving major clinical outcomes in STEMI patients undergoing primary PCI with DESs.
Abstract
Background/Aims: Transradial intervention (TRI) is becoming the preferred method over transfemoral intervention (TFI) because TRI is associated with lower incidence of major bleeding and vascular complications. However, there has been limited published data regarding the clinical outcomes of TRI versus TFI in Korean patients with ST-elevation myocardial infarction (STEMI). Methods: A total of 689 consecutive STEMI patients who underwent primary percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) from January to December of 2009 at nine university hospitals were enrolled in this study. Mid-term angiographic and 12-month cumulative clinical outcomes of the TRI group (n = 220, 31.9%) were compared to those of the TFI group (n = 469, 28.1%). Results: After propensity score matching, in-hospital complications and the 12-month major clinical outcomes during follow-up in the two groups were similar to each other. However, the incidence rates of repeat revascularization (6.4% vs. 0.5%, p = 0.003), target vessel revascularization (6.4% vs. 0.5%, p = 0.003), and major adverse cardiac events (MACE; 11.6% vs. 4.6%, p = 0.018) in the TFI group were higher than those in the TRI group during the 12-month of follow-up. Conclusions: In our study, TRI in STEMI patients undergoing primary PCI with DESs was associated with lower incidence of access site hematoma, 12-month repeat revascularization, and MACE compared to TFI. Therefore, TRI might play an important role in reducing bleeding complications while improving major clinical outcomes in STEMI patients undergoing primary PCI with DESs.
참고문헌 (20)
- Agostoni P, "Radial versus femoral approach for percutaneous coronary diagnostic and interventional procedures: systematic overview and meta-analysis of randomized trials", J Am Coll Cardiol, 44, pp.349~356 (2004)[DOI]
- Jolly SS, "Radial versus femoral access for coronary angiography or intervention and the impact on major bleeding and ischemic events: a systematic review and meta-analysis of randomized trials", Am Heart J, 157, pp.132~140 (2009)[DOI]
- Kinnaird TD, "Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions", Am J Cardiol, 92, pp.930~935 (2003)[DOI]
- Yatskar L, "Access site hematoma requiring blood transfusion predicts mortality in patients undergoing percutaneous coronary intervention: data from the National Heart, Lung, and Blood Institute Dynamic Registry", Catheter Cardiovasc Interv, 69, pp.961~966 (2007)[DOI]
- Oweida SW, "Postcatheterization vascular complications associated with percutaneous transluminal coronary angioplasty", J Vasc Surg, 12, pp.310~315 (1990)[DOI]
- Nasser TK, "Peripheral vascular complications following coronary interventional procedures", Clin Cardiol, 18, pp.609~614 (1995)[DOI]
- Jolly SS, "Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial", Lancet, 307, pp.1409~1420 (2011)
- Mehran R, "Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium", Circulation, 123, pp.2736~2747 (2011)[DOI]
- Cutlip DE, "Clinical end points in coronary stent trials: a case for standardized definitions", Circulation, 115, pp.2344~2351 (2007)[DOI]
- Kiemeneij F, "A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study", J Am Coll Cardiol, 29, pp.1269~1275 (1997)[DOI]
- Delarche N, "Direct angioplasty for acute myocardial infarction in elderly patients using transradial approach", Am J Geriatr Cardiol, 8, pp.32~35 (1999)
- Cooper CJ, "Effect of transradial access on quality of life and cost of cardiac catheterization: a randomized comparison", Am Heart J, 138, pp.430~436 (1999)[DOI]
- Mehta SR, "Effects of radial versus femoral artery access in patients with acute coronary syndromes with or without ST-segment elevation", J Am Coll Cardiol, 60, pp.2490~2499 (2012)[DOI]
- Romagnoli E, "Radial versus femoral randomized investigation in ST-segment elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study", J Am Coll Cardiol, 60, pp.2481~2489 (2012)[DOI]
- Byrne RA, "Vascular access and closure in coronary angiography and percutaneous intervention", Nat Rev Cardiol, 10, pp.27~40 (2013)[DOI]
- Saito S, "Comparative study on transradial approach vs. transfemoral approach in primary stent implantation for patients with acute myocardial infarction: results of the test for myocardial infarction by prospective unicenter randomization for access sites (TEMPURA) trial", Catheter Cardiovasc Interv, 59, pp.26~33 (2003)[DOI]
- Ellis SG, "In-hospital cost of percutaneous coronary revascularization: critical determinants and implications", Circulation, 92, pp.741~747 (1995)[DOI]
- Wolfe MW, "Length of hospital stay and complications after percutaneous transluminal coronary angioplasty: clinical and procedural predictors. Heparin Registry Investigators", Circulation, 92, pp.311~319 (1995)[DOI]
- Bernat I, "ST-segment elevation myocardial infarction treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-RADIAL trial", J Am Coll Cardiol, 63, pp.964~972 (2014)[DOI]
- Jolly SS, "Effect of radial versus femoral access on radiation dose and the importance of procedural volume: a substudy of the multicenter randomized RIVAL trial", JACC Cardiovasc Interv, 6, pp.258~266 (2013)[DOI]